Lifeboat Foundation

MIT physicists have observed signs of a rare type of superconductivity in a material called magic-angle twisted trilayer graphene. In a study appearing in Nature, the researchers report that the material exhibits superconductivity at surprisingly high magnetic fields of up to 10 Tesla, which is three times higher than what the material is predicted to endure if it were a conventional superconductor.

The results strongly imply that magic-angle trilayer graphene, which was initially discovered by the same group, is a very rare type of superconductor, known as a “spin-triplet,” that is impervious to high magnetic fields. Such exotic superconductors could vastly improve technologies such as magnetic resonance imaging, which uses superconducting wires under a magnetic field to resonate with and image biological tissue. MRI machines are currently limited to magnet fields of 1 to 3 Tesla. If they could be built with spin-triplet superconductors, MRI could operate under higher magnetic fields to produce sharper, deeper images of the human body.

The new evidence of spin-triplet superconductivity in trilayer graphene could also help scientists design stronger superconductors for practical quantum computing.

No instances of the rare disease had been recorded in the US since 2003.

We probably at this point should make all animals immortal: 3.

The advance promises to unlock new insights into human biology and disease, aiding in the study of everything from the developing immune system to tissue regeneration to skin cancer.

“Studying biodiversity is not just about exploring the biology of a bunch of interesting organisms, but ultimately for a better understanding of human biology,” developmental biologist and lead study author Hiroshi Kiyonari said via email.

Continue reading “Scientists produce first genetically engineered marsupials” »

The human trial of plasma dilution started in Russia last week. The lead researcher is checking how the biomarkers of aging will change in response to 110% plasma replacement during the therapy, and the difference between the group with albumin addition and without albumin. The trial is open to both Russian citizens and people from other countries. It is a hybrid model where part of the expenditures is paid by the volunteers, and part is provided by the patron of the research. This model allowed to get the trial started in record time — less than 9 months from conception to the start date.

The research group wants to test plasmapheresis in combination with other longevity therapies next to see if plasma dilution prior to the other therapy can enhance the results.

Continue reading “Clinical Trial: Does Plasma Dilution Delay Aging? | Lifespan News Extra” »

The makers of a luxury vehicle billed as a ‘flying motorcycle’ that can travel upwards of 300mph have completed flight testing their first prototype and are ready to take preorders.

Jetpack Aviation envisions its Speeder—a jet-powered, vertical takeoff and landing (VTOL) aircraft—as both a pleasure craft and a mission vehicle well-suited for medical teams and fire and rescue operations.

Continue reading “Flying motorcycle that can reach 300mph completes first flight test” »

A biotech company in upstate New York designs products made from the root structures of mushrooms. It takes about a week to grow their alternative to styrofoam packaging. And their vegan meat can be sliced into whole cuts and crisps up like bacon when fried.

varying in age between 18 and 88, only 33% of them said they would be willing to take a pill that allowed them to stay alive at their current age.

If you were asked to participate in this survey, would you be willing to take an immortality pill? Would it matter what age you were before taking it?

In this video, Drs Irina and Mike Conboy talk about their theory of why we age and introduce Neutral Blood Exchange, which came from their original parabiosis experiments documented in a 2005 paper.

Our guests today are Drs. Irina and Michael Conboy of the Department of Bioengineering at the University of California Berkeley. their discovery of the rejuvenating effects of young blood through parabiosis in a seminal paper published in Nature in 2005 paved the way for a thriving field of rejuvenation biology. The Conboy lab currently focuses on broad rejuvenation of tissue maintenance and repair, stem cell niche engineering, elucidating the mechanisms underlying muscle stem cell aging, directed organogenesis, and making CRISPR a therapeutic reality.

Continue reading “Our Theory Of Aging & Blood Dilution w/ Saline & Albumin | Drs. Irina & Mike Conboy Interview Ep 1” »

Great exclusive interview by longevity expert, PhD. Professor, Systems Biology. Director, Chronic Metabolic and Rare Diseases Systems Biology Initiative (ChroMe RaDSBIn) facebook.com/LifetimeTrustnet/posts/1021975448543419

Dr. Ancha Baranova interview on longevity and Covid technologies.

She discovered many biomarkers for chronic liver diseases, cancer and other illnesses, a biosynthesis of the melanin in human adipose, two novel properties of cell-free DNA, and a variety of novel functions for known biomolecules.